Puma Biotechnology Inc’s filing revealed that its Director WILSON TROY EDWARD unloaded Company’s shares for reported $36720.0 on Jun 13 ’25. In the deal valued at $3.40 per share,10,800 shares were sold. As a result of this transaction, WILSON TROY EDWARD now holds 43,550 shares worth roughly $0.15 million.
Then, Stuglik Brian M sold 8,100 shares, generating $27,459 in total proceeds. Upon selling the shares at $3.39, the Director now owns 94,958 shares.
Before that, Senderowicz Adrian sold 27,000 shares. Puma Biotechnology Inc shares valued at $91,800 were divested by the Director at a price of $3.40 per share. As a result of the transaction, Senderowicz Adrian now holds 27,000 shares, worth roughly $92610.0.
Citigroup upgraded its Puma Biotechnology Inc [PBYI] rating to a Buy from a a Neutral in a research note published recently. Goldman also remained covering PBYI and has decreased its forecast on October 08, 2019 with a “Sell” recommendation from previously “Neutral” rating. Citigroup revised its rating on May 10, 2019. It rated PBYI as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PBYI
On Tuesday, Puma Biotechnology Inc [NASDAQ:PBYI] saw its stock fall -0.58% to $3.43. Over the last five days, the stock has lost -4.72%. Puma Biotechnology Inc shares have risen nearly 12.46% since the year began. Nevertheless, the stocks have risen 3.31% over the past one year. While a 52-week high of $4.13 was reached on 01/07/25, a 52-week low of $2.22 was recorded on 04/09/25.
Levels Of Support And Resistance For PBYI Stock
The 24-hour chart illustrates a support level at 3.38, which if violated will result in even more drops to 3.33. On the upside, there is a resistance level at 3.49. A further resistance level may holdings at 3.55.
